Innoviva Debt to Equity Ratio 2006-2018 | INVA

Current and historical debt to equity ratio values for Innoviva (INVA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Innoviva debt/equity for the three months ending September 30, 2018 was 0.00.
Innoviva Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.38B $-0.11B -3.52
2018-06-30 $0.49B $-0.16B -3.13
2018-03-31 $0.49B $-0.21B -2.28
2017-12-31 $0.57B $-0.24B -2.37
2017-09-30 $0.58B $-0.22B -2.59
2017-06-30 $0.64B $-0.30B -2.15
2017-03-31 $0.70B $-0.33B -2.10
2016-12-31 $0.71B $-0.35B -2.01
2016-09-30 $0.72B $-0.37B -1.96
2016-06-30 $0.72B $-0.36B -1.99
2016-03-31 $0.74B $-0.36B -2.03
2015-12-31 $0.73B $-0.34B -2.14
2015-09-30 $0.74B $-0.32B -2.30
2015-06-30 $0.74B $-0.29B -2.51
2015-03-31 $0.73B $-0.26B -2.81
2014-12-31 $0.73B $-0.22B -3.25
2014-09-30 $0.71B $-0.19B -3.65
2014-06-30 $0.74B $-0.19B -3.93
2014-03-31 $0.29B $0.26B 1.09
2013-12-31 $0.29B $0.30B 0.96
2013-09-30 $0.29B $0.33B 0.87
2013-06-30 $0.46B $0.09B 5.37
2013-03-31 $0.46B $0.09B 5.03
2012-12-31 $0.17B $0.16B 1.11
2012-09-30 $0.17B $0.17B 1.00
2012-06-30 $0.17B $0.19B 0.91
2012-03-31 $0.17B $0.01B 28.14
2011-12-31 $0.17B $-0.09B -1.98
2011-09-30 $0.17B $-0.06B -2.92
2011-06-30 $0.17B $-0.04B -4.60
2011-03-31 $0.17B $-0.03B -6.20
2010-12-31 $0.17B $-0.02B -7.70
2010-09-30 $0.17B $-0.14B -1.22
2010-06-30 $0.17B $-0.13B -1.37
2010-03-31 $0.17B $-0.11B -1.53
2009-12-31 $0.17B $-0.19B -0.91
2009-09-30 $0.17B $-0.18B -0.99
2009-06-30 $0.17B $-0.16B -1.08
2009-03-31 $0.17B $-0.14B -1.20
2008-12-31 $0.17B $-0.14B -1.28
2008-09-30 $0.17B $-0.13B -1.38
2008-06-30 $0.17B $-0.11B -1.55
2008-03-31 $0.17B $-0.09B -1.91
2007-12-31 $0.00B $-0.07B -0.01
2007-09-30 $0.00B $-0.04B -0.01
2007-06-30 $0.00B $-0.02B -0.03
2007-03-31 $0.00B $0.02B 0.03
2006-12-31 $0.00B $0.06B 0.01
2006-09-30 $0.00B $0.09B 0.01
2006-06-30 $0.00B $0.13B 0.01
2006-03-31 $0.00B $0.16B 0.00
2005-12-31 $0.00B $0.06B 0.01
2005-09-30 $0.00B $0.10B 0.01
2005-06-30 $0.00B $0.13B 0.01
2005-03-31 $0.00B $0.16B 0.01
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.776B $0.217B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $125.156B 14.15
Gilead Sciences (GILD) United States $88.147B 10.61
Biogen (BIIB) United States $65.000B 13.16
Celgene (CELG) United States $49.577B 9.62
Illumina (ILMN) United States $49.527B 57.69
Vertex Pharmaceuticals (VRTX) United States $44.838B 78.33
Regeneron Pharmaceuticals (REGN) United States $40.899B 20.72
Alexion Pharmaceuticals (ALXN) United States $26.105B 17.86
BioMarin Pharmaceutical (BMRN) United States $16.829B 0.00
Incyte (INCY) United States $14.401B 398.06
Seattle Genetics (SGEN) United States $9.921B 0.00
Exact Sciences (EXAS) United States $8.823B 0.00
BeiGene (BGNE) Cayman Islands $8.430B 0.00
Sarepta Therapeutics (SRPT) United States $8.362B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.032B 0.00
QIAGEN (QGEN) Netherlands $8.002B 25.59
Bio-Rad Laboratories (BIO.B) United States $7.571B 48.41
Exelixis (EXEL) United States $6.518B 18.48
Bio-Techne Corp (TECH) United States $6.117B 41.32
Bluebird Bio (BLUE) United States $5.892B 0.00
Alkermes (ALKS) Ireland $5.516B 3550.00
Galapagos (GLPG) Belgium $5.475B 0.00
Amarin (AMRN) Ireland $5.419B 0.00
Immunomedics (IMMU) United States $3.708B 0.00
Guardant Health (GH) United States $3.639B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.601B 0.00
Array BioPharma (ARRY) United States $3.439B 0.00
Horizon Pharma Public (HZNP) Ireland $3.314B 13.63
Emergent Biosolutions (EBS) United States $3.290B 27.72
ARGENX SE-ADR (ARGX) Netherlands $3.285B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.283B 0.00
Allogene Therapeutics (ALLO) United States $3.184B 0.00
Ligand Pharmaceuticals (LGND) United States $3.144B 24.05
Akcea Therapeutics (AKCA) United States $2.880B 0.00
Repligen (RGEN) United States $2.660B 83.08
Ascendis Pharma (ASND) Denmark $2.631B 0.00
Genomic Health (GHDX) United States $2.628B 88.71
Allakos (ALLK) United States $2.601B 0.00
China Biologic Products (CBPO) China $2.571B 18.30
Blueprint Medicines (BPMC) United States $2.541B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.384B 0.00
Myriad Genetics (MYGN) United States $2.340B 23.18
ACADIA Pharmaceuticals (ACAD) United States $2.311B 0.00
Halozyme Therapeutics (HALO) United States $2.270B 50.65
Global Blood Therapeutics (GBT) United States $2.258B 0.00
MyoKardia (MYOK) United States $2.250B 0.00
Acceleron Pharma (XLRN) United States $2.209B 0.00
Arena Pharmaceuticals (ARNA) United States $2.108B 0.00
Amicus Therapeutics (FOLD) United States $2.077B 0.00
Denali Therapeutics (DNLI) United States $1.970B 0.00
Atara Biotherapeutics (ATRA) United States $1.938B 0.00
AnaptysBio (ANAB) United States $1.910B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.888B 0.00
Reata Pharmaceuticals (RETA) United States $1.801B 0.00
REGENXBIO (RGNX) United States $1.792B 24.04
Medicines (MDCO) United States $1.707B 0.00
Rubius Therapeutics (RUBY) United States $1.566B 0.00
Spark Therapeutics (ONCE) United States $1.560B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.519B 0.00
WAVE Life Sciences (WVE) Singapore $1.476B 0.00
Cambrex (CBM) United States $1.467B 10.95
Editas Medicine (EDIT) United States $1.449B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.394B 110.75
Aimmune Therapeutics (AIMT) United States $1.375B 0.00
Mirati Therapeutics (MRTX) United States $1.360B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.360B 0.00
Myovant Sciences (MYOV) United Kingdom $1.292B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.283B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.269B 0.00
G1 THERAPEUTICS (GTHX) United States $1.268B 0.00
Sangamo Therapeutics (SGMO) United States $1.252B 0.00
NeoGenomics (NEO) United States $1.239B 102.00
Zai Lab Unsponsored ADR (ZLAB) China $1.231B 0.00
Insmed (INSM) United States $1.220B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.210B 0.00
Lion Biotechnologies (IOVA) United States $1.203B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.180B 0.00
UniQure (QURE) Netherlands $1.102B 0.00
Clovis Oncology (CLVS) United States $1.096B 0.00
Fate Therapeutics (FATE) United States $1.084B 0.00
Retrophin (RTRX) United States $1.045B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.014B 0.00
Audentes Therapeutics (BOLD) United States $1.011B 0.00
Apellis Pharmaceuticals (APLS) United States $1.008B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.969B 0.00
Novavax (NVAX) United States $0.949B 0.00
Puma Biotechnology (PBYI) United States $0.921B 0.00
Athenex (ATNX) United States $0.899B 0.00
DBV Technologies (DBVT) France $0.887B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.842B 0.00
Intra-Cellular Therapies (ITCI) United States $0.838B 0.00
Cellectis (CLLS) France $0.838B 0.00
Solid Biosciences (SLDB) United States $0.828B 0.00
Revance Therapeutics (RVNC) United States $0.811B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.786B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.784B 0.00
Acorda Therapeutics (ACOR) United States $0.779B 9.86
Vericel (VCEL) United States $0.771B 0.00
Heska (HSKA) United States $0.761B 62.29
Y-mAbs Therapeutics (YMAB) United States $0.751B 0.00
Aptinyx (APTX) United States $0.737B 0.00
AC Immune SA (ACIU) Switzerland $0.731B 0.00
Dynavax Technologies (DVAX) United States $0.730B 0.00
Scholar Rock Holding (SRRK) United States $0.726B 0.00
Intellia Therapeutics (NTLA) United States $0.722B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.716B 0.00
Gritstone Oncology (GRTS) United States $0.716B 0.00
Principia Biopharma (PRNB) United States $0.702B 0.00
Viking Therapeutics (VKTX) United States $0.701B 0.00
InflaRx (IFRX) Germany $0.691B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.690B 0.00
Coherus BioSciences (CHRS) United States $0.682B 0.00
CytomX Therapeutics (CTMX) United States $0.676B 0.00
UNITY Biotechnology (UBX) $0.666B 0.00
ANI Pharmaceuticals (ANIP) United States $0.646B 12.35
UROGEN PHARMA (URGN) Israel $0.640B 0.00
Cara Therapeutics (CARA) United States $0.611B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
TWIST BIOSCIENC (TWST) United States $0.584B 0.00
AVROBIO (AVRO) United States $0.584B 0.00
Eidos Therapeutics (EIDX) United States $0.562B 0.00
ObsEva SA (OBSV) Switzerland $0.560B 0.00
Kezar Life Sciences (KZR) United States $0.560B 0.00
RA PHARMCTL INC (RARX) United States $0.553B 0.00
Kura Oncology (KURA) United States $0.550B 0.00
Arcus Biosciences (RCUS) United States $0.545B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.535B 0.00
Arvinas (ARVN) United States $0.511B 0.00
Inovio Pharmaceuticals (INO) United States $0.506B 0.00
Epizyme (EPZM) United States $0.500B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.496B 0.00
Zymeworks (ZYME) Canada $0.480B 0.00
Prothena (PRTA) Ireland $0.475B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
Replimune (REPL) United States $0.460B 0.00
Osiris Therapeutics (OSIR) United States $0.458B 0.00
Anika Therapeutics (ANIK) United States $0.446B 18.46
Achillion Pharmaceuticals (ACHN) United States $0.442B 0.00
PDL BioPharma (PDLI) United States $0.441B 7.19
Cytokineticsorporated (CYTK) United States $0.438B 0.00
Senesco Technologies (ELOX) United States $0.434B 0.00
Five Prime Therapeutics (FPRX) United States $0.427B 0.00
Kindred Biosciences (KIN) United States $0.426B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.424B 0.00
Zealand Pharma (ZEAL) Denmark $0.405B 4.47
Sinovac Biotech (SVA) China $0.403B 0.00
Mesoblast (MESO) Australia $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.397B 0.00
MediciNova (MNOV) United States $0.394B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.375B 0.00
Cellular Biomedicine (CBMG) United States $0.370B 0.00
ResTORbio (TORC) United States $0.369B 0.00
MeiraGTx Holdings (MGTX) United States $0.355B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.344B 0.00
Krystal Biotech (KRYS) United States $0.343B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.339B 0.00
Sorrento Therapeutics (SRNE) United States $0.333B 54.40
Liquidia Technologies (LQDA) United States $0.332B 0.00
Verastem (VSTM) United States $0.324B 0.00
Agenus (AGEN) United States $0.319B 0.00
Evelo Biosciences (EVLO) United States $0.316B 0.00
Albireo Pharma (ALBO) United States $0.305B 0.00
Kodiak Sciences (KOD) United States $0.303B 0.00
Seres Therapeutics (MCRB) United States $0.295B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.291B 0.00
Athersys (ATHX) United States $0.286B 0.00
MannKind (MNKD) United States $0.284B 0.00
Merus (MRUS) Netherlands $0.281B 0.00
LogicBio Therapeutics (LOGC) United States $0.273B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.271B 0.00
Geron (GERN) United States $0.270B 0.00
Magenta Therapeutics (MGTA) United States $0.263B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.258B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.257B 0.00
Intec Pharma (NTEC) Israel $0.256B 0.00
Arbutus Biopharma (ABUS) Canada $0.255B 0.00
BioDelivery Sciences (BDSI) United States $0.252B 0.00
Kadmon Holdings (KDMN) United States $0.240B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Celcuity (CELC) United States $0.233B 0.00
Equillium (EQ) United States $0.231B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Aduro Biotech (ADRO) United States $0.226B 0.00
TOCAGEN INC (TOCA) United States $0.224B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.223B 0.00
PSivida (EYPT) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.220B 0.00
Strongbridge Biopharma (SBBP) United States $0.213B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.211B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Kala Pharmaceuticals (KALA) United States $0.193B 0.00
Kamada (KMDA) Israel $0.193B 17.78
Urovant Sciences (UROV) United States $0.188B 0.00
Proteostasis Therapeutics (PTI) United States $0.187B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.185B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.182B 0.00
Idera Pharmaceuticals (IDRA) United States $0.182B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.174B 0.00
ChromaDex (CDXC) United States $0.169B 0.00
Protagonist Therapeutics (PTGX) United States $0.169B 0.00
BioTime (BTX) United States $0.165B 0.00
Compugen (CGEN) Israel $0.164B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.164B 0.00
Unum Therapeutics (UMRX) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Cohbar (CWBR) United States $0.157B 0.00
XBiotech (XBIT) United States $0.157B 0.00
Palatin Technologies (PTN) United States $0.156B 19.17
ASLAN Pharmaceuticals (ASLN) Singapore $0.153B 0.00
Constellation Pharmaceuticals (CNST) United States $0.151B 0.00
Axovant Sciences (AXON) United Kingdom $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.144B 0.00
Enzo Biochem (ENZ) United States $0.141B 0.00
Cerecor (CERC) United States $0.138B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.133B 0.00
Menlo Therapeutics (MNLO) United States $0.129B 0.00
Pfenex (PFNX) United States $0.127B 0.00
XOMA (XOMA) United States $0.124B 0.00
Selecta Biosciences (SELB) United States $0.123B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.121B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Catalyst Biosciences (CBIO) United States $0.120B 0.00
Mersana Therapeutics (MRSN) United States $0.120B 0.00
Applied Genetic Technologies (AGTC) United States $0.119B 0.00
Eleven Biotherapeutics (SESN) United States $0.119B 0.00
Spero Therapeutics (SPRO) United States $0.115B 0.00
NantKwest (NK) United States $0.115B 0.00
VBI Vaccines (VBIV) United States $0.107B 0.00
Cocrystal Pharma (COCP) United States $0.106B 118.00
Pluristem Therapeutics (PSTI) Israel $0.105B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.104B 0.00
Cue Biopharma (CUE) United States $0.102B 0.00
ETON PHARMACEUT (ETON) United States $0.102B 0.00
Neothetics (EVFM) United States $0.100B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Anavex Life Sciences (AVXL) United States $0.096B 0.00
Axsome Therapeutics (AXSM) United States $0.096B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.096B 0.00
Motif Bio Plc (MTFB) United States $0.093B 0.00
Chiasma (CHMA) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.092B 0.00
Cel-Sci (CVM) United States $0.091B 0.00
Aptose Biosciences (APTO) Canada $0.091B 0.00
Provention Bio (PRVB) United States $0.090B 0.00
ScPharmaceuticals (SCPH) United States $0.089B 0.00
Mustang Bio (MBIO) United States $0.088B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
OVID THERAPEUTC (OVID) United States $0.076B 0.00
VolitionRX (VNRX) Singapore $0.075B 0.00
ITUS (ANIX) United States $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
BioXcel Therapeutics (BTAI) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Monster Digital (INNT) United States $0.069B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.066B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.065B 0.00
Sophiris Bio (SPHS) United States $0.065B 0.00
Prima BioMed (IMMP) Australia $0.063B 0.00
Fortress Biotech (FBIO) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Ophthotech (OPHT) United States $0.060B 0.00
Alcobra (ARCT) United States $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Arsanis (ASNS) United States $0.056B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
AEterna Zentaris (AEZS) United States $0.054B 10.31
Versartis (ARAV) United States $0.053B 4.69
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.053B 0.00
Entera Bio (ENTX) Israel $0.053B 0.00
Trevena (TRVN) United States $0.051B 0.00
Aptevo Therapeutics (APVO) United States $0.049B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Asterias Biotherapeutics (AST) United States $0.048B 0.00
Celldex Therapeutics (CLDX) United States $0.047B 0.00
Caladrius Biosciences (CLBS) United States $0.047B 0.00
Leap Therapeutics (LPTX) United States $0.046B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.043B 0.00
Zosano Pharma (ZSAN) United States $0.043B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.039B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Oncobiologics (OTLK) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Galena Biopharma (SLS) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.44
Histogenics (HSGX) United States $0.033B 0.00
TRACON Pharmaceuticals (TCON) United States $0.033B 0.00
AquaBounty Technologies (AQB) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
AZURRX BIOPHARM (AZRX) United States $0.030B 0.00
GTx (GTXI) United States $0.030B 0.00
Oragenics (OGEN) United States $0.029B 0.00
DiaMedica Therapeutics (DMAC) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Benitec Biopharma (BNTC) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
CytRx (CYTR) United States $0.018B 0.00
GENPREX INC (GNPX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cellect Biotechnology (APOP) Israel $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 8.40
Soligenix (SNGX) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.015B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.015B 0.00
Edge Therapeutics (EDGE) United States $0.014B 0.00
Gemphire Therapeutics (GEMP) United States $0.014B 0.00
Adial Pharmaceuticals (ADIL) United States $0.013B 0.00
Prana Biotechnology (PRAN) Australia $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Vital Therapies (VTL) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Cerulean Pharma (DARE) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Aytu Bioscience (AYTU) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00